Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
China Medical University has 8 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 8 distinct examiners, meaning each examiner is responsible for 1 case. The portfolio spans 8 distinct art units, showing a high degree of technical diversity within the pharmaceutical field.
ALAAELDIN M ELSHAER is the busiest examiner, handling 1 pending office action. Since there are 8 pending office actions and 8 distinct examiners, the workload is evenly spread. This lack of examiner concentration suggests that prosecution strategies must be tailored to 8 different individual perspectives within the Biotechnology & Pharmaceuticals area.
The 8 distinct art units involved suggest that while the technology area is Biotechnology & Pharmaceuticals, the specific sub-specialties are varied. With 8 distinct examiners involved, the university faces a wide array of examination approaches. This profile demonstrates a high degree of examiner and art unit diversity relative to the 8 pending office actions currently active.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (12%) |
| §101 + other | 1 (12%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 5 (62%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ELSHAER, ALAAELDIN M | 1 | 36.1% | +30.5% |
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
| EBBINGHAUS, BRIANA NOEL | 1 | 61.6% | +63.5% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.7% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| HOPKINS, SAMANTHA LAKE | 1 | 60.4% | +62.3% |
| O'NEILL, MARISOL ANN | 1 | 53.1% | +68.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18906484 | EXPLAINABLE ARTIFICIAL INTELLIGENCE METHOD APPLIED TO CLINICAL MEDICINE AND SYSTEM THEREOF AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM | ELSHAER, ALAAELDIN M | — |
| 18802834 | Exosomes for treating glioblastoma multiforme and manufacturing method thereof | MERCIER, MELISSA S | — |
| 18761628 | CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF | EBBINGHAUS, BRIANA NOEL | — |
| 18434050 | SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF | AZPURU, CARLOS A | — |
| 18425313 | EXOSOME, PREPARATION METHOD THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITION | CANDELARIA, JULIANA IRENE | — |
| 18347217 | METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE | RODRIGUEZ, RAYNA B | — |
| 17776284 | Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type | O'NEILL, MARISOL ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17746112 | VACCINE AND METHOD FOR TREATING CANCER | HOPKINS, SAMANTHA LAKE | 22d |
| 18906484 | EXPLAINABLE ARTIFICIAL INTELLIGENCE METHOD APPLIED TO CLINICAL MEDICINE AND SYSTEM THEREOF AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM | ELSHAER, ALAAELDIN M | — |
| 18761628 | CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF | EBBINGHAUS, BRIANA NOEL | — |
| 18434050 | SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF | AZPURU, CARLOS A | — |
| 18347217 | METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE | RODRIGUEZ, RAYNA B | — |
| 17776284 | Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type | O'NEILL, MARISOL ANN | — |
| Art Unit | Apps |
|---|---|
| 3687 | 1 |
| 1615 | 1 |
| 1613 | 1 |
| 1617 | 1 |
| 1634 | 1 |
| 1628 | 1 |
| 1641 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18906484 | EXPLAINABLE ARTIFICIAL INTELLIGENCE METHOD APPLIED TO CLINICAL MEDICINE AND SYSTEM THEREOF AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM | ELSHAER, ALAAELDIN M | 3687 | §101 | Non-Final OA | — | Pending | Oct 04, 2024 |
| 18802834 | Exosomes for treating glioblastoma multiforme and manufacturing method thereof | MERCIER, MELISSA S | 1615 | §103§112 | Final Rejection | — | Pending | Aug 13, 2024 |
| 18761628 | CELL REPAIR-PROMOTING EXTRACELLULAR VESICLE, PRODUCTION METHOD, PREPARATION, AND USE THEREOF | EBBINGHAUS, BRIANA NOEL | 1613 | §101§103§112 | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18434050 | SOLUTION FOR PRESERVING EXTRACELLULAR VESICLES/EXOSOMES, METHOD FOR PRESERVING THE SAME, AND MIXED SOLUTION THEREOF | AZPURU, CARLOS A | 1617 | §103§112 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18425313 | EXOSOME, PREPARATION METHOD THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITION | CANDELARIA, JULIANA IRENE | 1634 | §103§112 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18347217 | METHOD FOR REGULATING DOWNSTREAM SIGNALING PATHWAY MEDIATED BY ACTIVATION OF TRIMETHYLAMINE-N-OXIDE | RODRIGUEZ, RAYNA B | 1628 | §102§103 | Non-Final OA | — | Pending | Jul 05, 2023 |
| 17746112 | VACCINE AND METHOD FOR TREATING CANCER | HOPKINS, SAMANTHA LAKE | 1641 | §112 | Final Rejection | 22d | Pending | May 17, 2022 |
| 17776284 | Method For Treating Cancer With Xenogeneic Tissue Cell Composition Of Similar Or Same Histological Type | O'NEILL, MARISOL ANN | 1633 | §102§103§112 | Final Rejection | — | Pending | May 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial